Breast, Prostate, and Rectal Cancer: Should 5-5-5 Be a New Standard of Care?
- PMID: 32890517
- PMCID: PMC7462831
- DOI: 10.1016/j.ijrobp.2020.06.049
Breast, Prostate, and Rectal Cancer: Should 5-5-5 Be a New Standard of Care?
References
-
- Braunstein LZ, Gillespie EF, Hong L, et al. Breast radiotherapy under COVID-19 pandemic resource constraints—Approaches to defer or shorten treatment from a comprehensive cancer center in the United States [e-pub ahead of print]. Adv Radiat Oncol. https://doi.org/10.1016/j.adro.2020.03.013. Accessed July 1, 2020. - DOI - PMC - PubMed
-
- Zaorsky NG, Yu JB, McBride SM, et al. Prostate cancer radiotherapy recommendations in response to COVID-19 [e-pub ahead of print]. Adv Radiat Oncol. https://doi.org/10.1016/j.adro.2020.03.010. Accessed July 1, 2020. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical